United Health Products (OTCMKTS:UEEC) versus Bio-Rad Laboratories (NYSE:BIO) Head-To-Head Survey

United Health Products (OTCMKTS:UEEC) and Bio-Rad Laboratories (NYSE:BIO) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability and risk.

Volatility and Risk

United Health Products has a beta of -0.3, indicating that its share price is 130% less volatile than the S&P 500. Comparatively, Bio-Rad Laboratories has a beta of 1.06, indicating that its share price is 6% more volatile than the S&P 500.

Earnings & Valuation

This table compares United Health Products and Bio-Rad Laboratories”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
United Health Products	N/A	N/A	-$2.67 million	($0.01)	-6.90
Bio-Rad Laboratories	$2.59 billion	2.65	$759.90 million	$6.07	41.90

Bio-Rad Laboratories has higher revenue and earnings than United Health Products. United Health Products is trading at a lower price-to-earnings ratio than Bio-Rad Laboratories, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for United Health Products and Bio-Rad Laboratories, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
United Health Products	0	0	0	0	0.00
Bio-Rad Laboratories	1	3	1	0	2.00

Bio-Rad Laboratories has a consensus price target of $333.00, indicating a potential upside of 30.92%. Given Bio-Rad Laboratories’ stronger consensus rating and higher possible upside, analysts plainly believe Bio-Rad Laboratories is more favorable than United Health Products.

Insider and Institutional Ownership

0.1% of United Health Products shares are owned by institutional investors. Comparatively, 65.2% of Bio-Rad Laboratories shares are owned by institutional investors. 1.5% of United Health Products shares are owned by insiders. Comparatively, 30.3% of Bio-Rad Laboratories shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares United Health Products and Bio-Rad Laboratories’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
United Health Products	N/A	N/A	-1,787.77%
Bio-Rad Laboratories	6.52%	3.56%	2.49%

Summary

Bio-Rad Laboratories beats United Health Products on 13 of the 13 factors compared between the two stocks.

About United Health Products

United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.